Cargando…
Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway
Parkinson’s disease (PD) is a common neurodegenerative disease with global health and economic impact. 1-methyl-4-phenylpyridinium (MPP+)-induced mitochondrial dysfunction and oxidative stress are reported to participate in the pathological mechanism of PD. Ramelteon is a novel oral hypnotic agent t...
Autores principales: | Li, Chuo, Zhang, Yusheng, Liu, Rongrong, Mai, Yuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806746/ https://www.ncbi.nlm.nih.gov/pubmed/34346829 http://dx.doi.org/10.1080/21655979.2021.1960767 |
Ejemplares similares
-
Proteomic analysis of S-nitrosylation induced by 1-methyl-4-phenylpyridinium (MPP(+))
por: Komatsubara, Akira T, et al.
Publicado: (2012) -
Inhibitory effects of curcumin and cyclocurcumin in 1-methyl-4-phenylpyridinium (MPP(+)) induced neurotoxicity in differentiated PC12 cells
por: Chakraborty, Sandeep, et al.
Publicado: (2017) -
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade
por: Zawada, W Michael, et al.
Publicado: (2011) -
The neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) alters hippocampal excitatory synaptic transmission by modulation of the GABAergic system
por: Huang, YuYing, et al.
Publicado: (2015) -
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP(+)) and 6-Hydroxydopamine (6-OHDA)
por: Carli, Marco, et al.
Publicado: (2021)